Sort
23,748 grants matching “melanoma”
CANCER AND LEUKEMIA GROUP B
$105,261Rhode Island Hospital (Providence, Ri) · U10 · FY2000 · CA
Core B: Pathology Core
$105,214Meenhard Herlyn · Wistar Institute · P01 · FY2016 · CA
Core B: Pathology Core
$105,201Meenhard Herlyn · Wistar Institute · P01 · FY2017 · CA
An integrated approach to melanoma metastasis and therapy resistance: effects of age-related changes in the ECM and the biomechanics of the skin
$105,092Ashani T Weeraratna · Johns Hopkins University · R01 · FY2021 · CA
Characterization of Cancer Transcriptomes using Next Generation Sequencing
$105,068Christopher A Maher · University Of Michigan At Ann Arbor · K99 · FY2011 · CA
Reviving cancer immune surveillance with CD4 T cell help
$105,021Michael Clavon Brown · Duke University · K99 · FY2021 · CA
Adaptive regulation of cancer cell fate following oncogene inhibition
$105,000Mohammad Fallahi-Sichani · University Of Virginia · R00 · FY2019 · CA
Eastern Cooperative Oncology Group
$104,956Michael B Atkins · Beth Israel Deaconess Medical Center · U10 · FY2010 · CA
Identifying Microenvironmental Factors Regulating Melanoma Promotion and Immune Evasion
$104,944Hyeongsun Moon · University Of California At Davis · K01 · FY2021 · OD
Identifying Microenvironmental Factors Regulating Melanoma Promotion and Immune Evasion
$104,944Hyeongsun Moon · University Of California At Davis · K01 · FY2022 · OD
Cushing's Disease Whole Exome Sequencing Study
$104,918James Mills · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2020 · HD
TUMOR VACCINES FOR THE TREATMENT OF ORAL MELANOMA
$104,897University Of Wisconsin Madison · R01 · FY2001 · DE
Immunologic & Genetic Determinants of Outcome & Response to IFN-a2b Therapy
$104,848John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2008 · CA
Toward safe, systemic immunotherapies for treatment of metastatic disease: Developing dendritic cell-biased immunomodulators with precise control over magnitude and timing of immune stimulation
$104,840Sachin Bhagchandani · Yale University · K00 · FY2024 · CA
CUTANEOUS ONCOLOGY
$104,777University Of Texas Md Anderson Can Ctr · K24 · FY2002 · CA
Consolidated Basic Cancer Research Program
$104,776Dario C. Altieri · Wistar Institute · P30 · FY2020 · CA
PREPHASE I GENE/IMMUNE THERAPY OF MALIGNANT BRAIN TUMOR
$104,590Rush University Medical Center · R01 · FY2000 · CA
Genomic Instability in Melanoma Pathogenesis
$104,557University Of Pennsylvania · K08 · FY2002 · CA
Melanoma in p16INK4a and p19ARF Deficient Mice
$104,504Dana-Farber Cancer Institute · K08 · FY2002 · CA
Hypoxia induces SHMT2 to regulate cellular redox and epigenetics
$104,417Jiangbin Ye · Sloan-Kettering Inst Can Research · K99 · FY2015 · CA
Hypoxia induces SHMT2 to regulate cellular redox and epigenetics
$104,417Jiangbin Ye · Sloan-Kettering Inst Can Research · K99 · FY2016 · CA
02 - Experimental Therapeutics
$104,387Narendra Wajapeyee · University Of Alabama At Birmingham · P30 · FY2024 · CA
02 - Experimental Therapeutics
$104,385Eddy Yang · University Of Alabama At Birmingham · P30 · FY2022 · CA
02 - Experimental Therapeutics
$104,385Eddy Yang · University Of Alabama At Birmingham · P30 · FY2023 · CA
Mayo Comprehensive Cancer Center Grant
$104,369Robert B. Diasio · Mayo Clinic Rochester · P30 · FY2010 · CA